Part B - Surviving Blood Loss: First in Human Studies to Assess Safety and Physiological Effects of Synthetic Ethinyl Estradiol-3-Sulfate (EE·3·SO4) in Healthy Subjects, Both Euvolemic and Following 10-20% Iatrogenic Blood Loss

Grant

Date/time Interval

  • September 19, 2015 - September 18, 2018
  • Total Award Amount

  • 1737715.00
  • Direct Costs

  • 1188345.00
  • Sponsor Award Id

  • W911QY-15-C-0134
  • Contributor

  • Chaudry, Irshad   Principal Investigator  
  • Hubbard, William   Investigator